Clinical Trial Update: A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study of a malaria vaccine, assessing immunogenicity, tolerability, safety, and protective efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Malaria vaccine

Snippet

Sponsor: Crucell Holland BV | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED